MARTINSRIED/MUNICH, Germany & PRINCETON, N.J.--(BUSINESS WIRE)--GPC Biotech AG (Frankfurt Stock Exchange: GPC; NASDAQ: GPCB) today announced that data from several satraplatin clinical trials will be presented at the 44th American Society of Clinical Oncology (ASCO) Annual Meeting taking place in Chicago, Ill., May 30-June 3, 2008.
